(PharmaNewsWire.Com, January 07, 2017 ) Migraine Drugs Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Migraine Drugs globally.
The Migraine Drugs Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Migraine Drugs Market:
Allergan Endo International GlaxoSmithKline Impax Pfizer
Other Prominent Vendors of Migraine Drugs Market Are:
“One market trend to watch for is the development and availability of antimigraine devices and headbands. Antimigraine drugs are associated with various side effects and show less tolerance among the patients. Thus, the need for new treatment options has led to the development of various devices in the market. Antimigraine devices and headbands are being increasingly preferred for the prevention of migraines. The FDA has approved Cerena Transcranial Magnetic Stimulator and the Cefaly Transcutaneous Electrical Nerve Stimulation device for migraine treatment. Cefaly is a plastic headband, which can be worn across the forehead.”
According to the Migraine Drugs Market report, a key market driver is the unmet needs of migraine sufferers around the world. Prophylactic therapy with improved efficacy and tolerability is one of the most significant unmet needs in individuals suffering from migraine. The US Agency for Healthcare Research and Quality estimated that only about 12% of the adults with migraines take preventive medications. The occurrence of side effects is the major reason that limits the use of migraine drugs. Moreover, there are still high levels of unmet need existing in certain niche populations, especially in patients who do not respond satisfactorily to triptans or patients for whom triptans are contraindicated.
Report also presents Geographical Segmentation analysis of Migraine Drugs Market of Americas, APAC, EMEA region.
Further, the Migraine Drugs Market report states that a challenge that could have a big impact on market growth is the lack of proper diagnosis of migraines.
Key questions answered in Migraine Drugs market report:
What will the Migraine Drugs market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving Migraine Drugs market? What are the challenges to Migraine Drugs market growth? Who are the key vendors in Migraine Drugs market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
